Surgery Partners, Inc.
US ˙ NasdaqGS ˙ US86881A1007

SecuritySGRY / Surgery Partners, Inc.
InsiderWilliam Trenton Webb
This page shows the track record and history of Webb William Trenton insider trades in Surgery Partners, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by William Trenton Webb in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by William Trenton Webb in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-03-06 272 13.9300 272 13.9300 3,789 21 11.4900 -663 -17.50
2026-03-05 1,794 13.8600 1,794 13.8600 24,865
2025-03-14 138 23.7000 138 23.7000 3,271
2025-03-10 2,057 24.0600 2,057 24.0600 49,491
2025-02-04 257 25.7000 257 25.7000 6,605

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-03-09 2026-03-06 4 Webb William Trenton SGRY Common Stock S - Sale D 13.9300 -272 -4 74,249
2026-03-09 2026-03-05 4 Webb William Trenton SGRY Common Stock A - Award D 14.1100 11,438 161 104,347
2026-03-09 2026-03-05 4 Webb William Trenton SGRY Common Stock A - Award D 14.1100 20,454 289 92,909
2026-03-09 2026-03-05 4 Webb William Trenton SGRY Common Stock S - Sale D 13.8600 -1,794 -25 72,455
2025-03-17 2025-03-14 4 Webb William Trenton SGRY Common Stock S - Sale D 23.7000 -138 -3 74,521
2025-03-13 2025-03-10 4 Webb William Trenton SGRY Common Stock S - Sale D 24.0600 -2,057 -49 74,659
2025-03-06 2025-03-04 4 Webb William Trenton SGRY Common Stock A - Award D 23.8000 3,781 90 76,716
2025-03-06 2025-03-04 4 Webb William Trenton SGRY Common Stock A - Award D 23.8000 12,605 300 72,935
2025-02-04 2025-02-04 4 Webb William Trenton SGRY Common Stock S - Sale D 25.7000 -257 -7 60,330
2025-02-04 2025-01-31 4 Webb William Trenton SGRY Common Stock A - Award D 3,207 60,587
2024-09-04 3 Webb William Trenton SGRY Common Stock D 55,503
2024-09-04 2024-09-01 4 Webb William Trenton SGRY Common Stock A - Award D 31.9500 1,877 60 57,380
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)